产品信息
| 产品号 | 商品名 | 活性成分 | 剂型/给药途径 | 规格/剂量 | 参比药物(RLD) | 生物等效参考标准(RS) | 治疗等效代码 | 该申请号批准日期 | 该产品号批准日期 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|
| 001 | MOUNJARO (AUTOINJECTOR) | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 2.5MG/0.5ML (2.5MG/0.5ML) | Yes | Yes | None | 2022/05/13 | 2022/05/13 | Prescription |
| 002 | MOUNJARO (AUTOINJECTOR) | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 5MG/0.5ML (5MG/0.5ML) | Yes | Yes | None | 2022/05/13 | Prescription | |
| 003 | MOUNJARO (AUTOINJECTOR) | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 7.5MG/0.5ML (7.5MG/0.5ML) | Yes | Yes | None | 2022/05/13 | Prescription | |
| 004 | MOUNJARO (AUTOINJECTOR) | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 10MG/0.5ML (10MG/0.5ML) | Yes | Yes | None | 2022/05/13 | Prescription | |
| 005 | MOUNJARO (AUTOINJECTOR) | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 12.5MG/0.5ML (12.5MG/0.5ML) | Yes | Yes | None | 2022/05/13 | Prescription | |
| 006 | MOUNJARO (AUTOINJECTOR) | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 15MG/0.5ML (15MG/0.5ML) | Yes | Yes | None | 2022/05/13 | Prescription | |
| 007 | MOUNJARO | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 2.5MG/0.5ML (2.5MG/0.5ML) | Yes | Yes | None | 2023/07/28 | Prescription | |
| 008 | MOUNJARO | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 5MG/0.5ML (5MG/0.5ML) | Yes | Yes | None | 2023/07/28 | Prescription | |
| 009 | MOUNJARO | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 7.5MG/0.5ML (7.5MG/0.5ML) | Yes | Yes | None | 2023/07/28 | Prescription | |
| 010 | MOUNJARO | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 10MG/0.5ML (10MG/0.5ML) | Yes | Yes | None | 2023/07/28 | Prescription | |
| 011 | MOUNJARO | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 12.5MG/0.5ML (12.5MG/0.5ML) | Yes | Yes | None | 2023/07/28 | Prescription | |
| 012 | MOUNJARO | TIRZEPATIDE | SOLUTION;SUBCUTANEOUS | 15MG/0.5ML (15MG/0.5ML) | Yes | Yes | None | 2023/07/28 | Prescription |
